Toxic erythema as the first sign of COVID‐19 infection

During the COVID‐19 pandemic, dermatologists have sought to identify and categorize skin manifestations associated with COVID‐19, in the hope that it will aid early recognition and treatment of the condition, as well as , provide insight into the pathophysiology of the disease. Urticarial, purpuric,...

Full description

Saved in:
Bibliographic Details
Published in:Clinical and Experimental Dermatology 2021-06
Main Authors: Hunjan, M K, Zuzarte, L, Bardhan, A, Karim, S, Heagarty, A
Format: Article
Language:English
Online Access:Request full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by
cites
container_end_page
container_issue
container_start_page
container_title Clinical and Experimental Dermatology
container_volume
creator Hunjan, M K
Zuzarte, L
Bardhan, A
Karim, S
Heagarty, A
description During the COVID‐19 pandemic, dermatologists have sought to identify and categorize skin manifestations associated with COVID‐19, in the hope that it will aid early recognition and treatment of the condition, as well as , provide insight into the pathophysiology of the disease. Urticarial, purpuric, maculopapular and acral rashes have been described in the literature to date (1) (2).
doi_str_mv 10.1111/ced.14571
format article
fullrecord <record><control><sourceid>proquest_COVID</sourceid><recordid>TN_cdi_proquest_journals_2480580833</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2480580833</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3981-c195441da72cdc5d9c0b5d379db354fc67d498fd410df9b1538b8bbca2db7e843</originalsourceid><addsrcrecordid>eNotjTtOAzEURd2kQAkFO7BEPcFvbGO7RMMvUqQ0gTay37PBiIzDeCJBxxJYIythpHCbc6pzGbsAsYRpVxhpCUobOGN2Wz4z8jh8ja9x77mvfBKe8lBHXvNLz0vi3eZ5dfv7_QOO5z5FHHPpF2yW_HuN5_-cs6f7u2332Kw3D6vuZt2gdBYaBKeVAvKmRUJNDkXQJI2jILVKeG1IOZtIgaDkAmhpgw0BfUvBRKvknF2euoehfBxjHXdv5Tj00-WuVVZoK6yU8g_lgkDY</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2480580833</pqid></control><display><type>article</type><title>Toxic erythema as the first sign of COVID‐19 infection</title><source>Coronavirus Research Database</source><creator>Hunjan, M K ; Zuzarte, L ; Bardhan, A ; Karim, S ; Heagarty, A</creator><creatorcontrib>Hunjan, M K ; Zuzarte, L ; Bardhan, A ; Karim, S ; Heagarty, A</creatorcontrib><description>During the COVID‐19 pandemic, dermatologists have sought to identify and categorize skin manifestations associated with COVID‐19, in the hope that it will aid early recognition and treatment of the condition, as well as , provide insight into the pathophysiology of the disease. Urticarial, purpuric, maculopapular and acral rashes have been described in the literature to date (1) (2).</description><identifier>DOI: 10.1111/ced.14571</identifier><language>eng</language><publisher>Hoboken: John Wiley &amp; Sons, Inc</publisher><ispartof>Clinical and Experimental Dermatology, 2021-06</ispartof><rights>2021. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the associated terms available at https://novel-coronavirus.onlinelibrary.wiley.com</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/2480580833?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>780,784,27925,38516,43895</link.rule.ids><linktorsrc>$$Uhttps://www.proquest.com/docview/2480580833?pq-origsite=primo$$EView_record_in_ProQuest$$FView_record_in_$$GProQuest</linktorsrc></links><search><creatorcontrib>Hunjan, M K</creatorcontrib><creatorcontrib>Zuzarte, L</creatorcontrib><creatorcontrib>Bardhan, A</creatorcontrib><creatorcontrib>Karim, S</creatorcontrib><creatorcontrib>Heagarty, A</creatorcontrib><title>Toxic erythema as the first sign of COVID‐19 infection</title><title>Clinical and Experimental Dermatology</title><description>During the COVID‐19 pandemic, dermatologists have sought to identify and categorize skin manifestations associated with COVID‐19, in the hope that it will aid early recognition and treatment of the condition, as well as , provide insight into the pathophysiology of the disease. Urticarial, purpuric, maculopapular and acral rashes have been described in the literature to date (1) (2).</description><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>COVID</sourceid><recordid>eNotjTtOAzEURd2kQAkFO7BEPcFvbGO7RMMvUqQ0gTay37PBiIzDeCJBxxJYIythpHCbc6pzGbsAsYRpVxhpCUobOGN2Wz4z8jh8ja9x77mvfBKe8lBHXvNLz0vi3eZ5dfv7_QOO5z5FHHPpF2yW_HuN5_-cs6f7u2332Kw3D6vuZt2gdBYaBKeVAvKmRUJNDkXQJI2jILVKeG1IOZtIgaDkAmhpgw0BfUvBRKvknF2euoehfBxjHXdv5Tj00-WuVVZoK6yU8g_lgkDY</recordid><startdate>202106</startdate><enddate>202106</enddate><creator>Hunjan, M K</creator><creator>Zuzarte, L</creator><creator>Bardhan, A</creator><creator>Karim, S</creator><creator>Heagarty, A</creator><general>John Wiley &amp; Sons, Inc</general><scope>COVID</scope></search><sort><creationdate>202106</creationdate><title>Toxic erythema as the first sign of COVID‐19 infection</title><author>Hunjan, M K ; Zuzarte, L ; Bardhan, A ; Karim, S ; Heagarty, A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3981-c195441da72cdc5d9c0b5d379db354fc67d498fd410df9b1538b8bbca2db7e843</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Hunjan, M K</creatorcontrib><creatorcontrib>Zuzarte, L</creatorcontrib><creatorcontrib>Bardhan, A</creatorcontrib><creatorcontrib>Karim, S</creatorcontrib><creatorcontrib>Heagarty, A</creatorcontrib><collection>Coronavirus Research Database</collection><jtitle>Clinical and Experimental Dermatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Hunjan, M K</au><au>Zuzarte, L</au><au>Bardhan, A</au><au>Karim, S</au><au>Heagarty, A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toxic erythema as the first sign of COVID‐19 infection</atitle><jtitle>Clinical and Experimental Dermatology</jtitle><date>2021-06</date><risdate>2021</risdate><abstract>During the COVID‐19 pandemic, dermatologists have sought to identify and categorize skin manifestations associated with COVID‐19, in the hope that it will aid early recognition and treatment of the condition, as well as , provide insight into the pathophysiology of the disease. Urticarial, purpuric, maculopapular and acral rashes have been described in the literature to date (1) (2).</abstract><cop>Hoboken</cop><pub>John Wiley &amp; Sons, Inc</pub><doi>10.1111/ced.14571</doi><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier DOI: 10.1111/ced.14571
ispartof Clinical and Experimental Dermatology, 2021-06
issn
language eng
recordid cdi_proquest_journals_2480580833
source Coronavirus Research Database
title Toxic erythema as the first sign of COVID‐19 infection
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T12%3A33%3A22IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_COVID&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toxic%20erythema%20as%20the%20first%20sign%20of%20COVID%E2%80%9019%20infection&rft.jtitle=Clinical%20and%20Experimental%20Dermatology&rft.au=Hunjan,%20M%20K&rft.date=2021-06&rft_id=info:doi/10.1111/ced.14571&rft_dat=%3Cproquest_COVID%3E2480580833%3C/proquest_COVID%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3981-c195441da72cdc5d9c0b5d379db354fc67d498fd410df9b1538b8bbca2db7e843%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2480580833&rft_id=info:pmid/&rfr_iscdi=true